ReviewJournal of neuro-oncology2008
New prospects for management and treatment of inoperable and recurrent skull base meningiomas.
Review in Journal of neuro-oncology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Neuroanatomical insights into neuro-ophthalmic presentations of skull base meningiomas: Pathways to precision medicine - A meta-analysis.Surgical neurology international · 2024Review
- Skull Base Meningiomas.Advances in experimental medicine and biology · 2023Article
- Emerging Medical Treatments for Meningioma in the Molecular Era.Biomedicines · 2018Review
- Predictors of Treatment Response and Survival Outcomes in Meningioma Recurrence with Atypical or Anaplastic Histology.Neurosurgery · 2018Article
- Light at the end of the tunnel: towards an effective drug therapy for surgery- and radiation-refractory meningioma.Neuro-oncology · 2015Article
- Cucurbitacin I blocks cerebrospinal fluid and platelet derived growth factor-BB stimulation of leptomeningeal and meningioma DNA synthesis.BMC complementary and alternative medicine · 2013Article
- Imatinib mesylate treatment of recurrent meningiomas in preselected patients: a retrospective analysis.Journal of neuro-oncology · 2012Article
- Lopinavir inhibits meningioma cell proliferation by Akt independent mechanism.Journal of neuro-oncology · 2011Article
- Medical therapies for meningiomas.Journal of neuro-oncology · 2010Review
- Gamma knife radiosurgery of meningiomas involving the foramen magnum.Journal of craniovertebral junction & spine · 2010Article
- Management options for cavernous sinus meningiomas.Journal of neuro-oncology · 2009Review
- Human epidermal growth factor receptor 2/neu protein expression in meningiomas: An immunohistochemical study.Journal of neurosciences in rural practiceArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skull base, including optic nerve, cavernous sinus, clival and foramen magnum tumors represent a major challenge for neurosurgeons and neuro-oncologists. Growth regulatory signaling pathways for these tumors are of increasing interest as potential targets for new chemotherapy. Those differentially activated in various grades of meningiomas are currently being identified as well. This article reviews some recent findings pathways that appear to regulate meningioma growth. Potential targets for novel therapies are also discussed.
Indexed as
Identifiers
17624496What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.